Filgrastim biosimilar (Apotex/Intas)

非格司亭生物类似药 (Apotex/Intas)

Report date: 2026/01/23 10:11:16

Base Information

Drug NameFilgrastim biosimilar (Apotex/Intas)
Drug Alias Name非格司亭生物仿制药（Apotex/Intas）rhG-CSF (Apotex/Intas)Recombinant human granulocyte macrophage colony stimulating factor (Apotex/Intas)重组人粒细胞刺激因子（Apotex/Intas）GCSF +[13] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsFebrile NeutropeniaNeutropenia
Global Approved IndicationsFebrile NeutropeniaNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2004/01/01
Country/TerritoryUnited StatesIndiaEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesApotexIntas Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesAccord Biopharma IncScigen Ltd
Inactive CompaniesAccord Healthcare Slu
Active IndicationsFebrile NeutropeniaNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksDrugBankKEGG